Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Strength Training And Aerobic Exercise Both Lower Cardiovascular Risks, Reduce Pain
Different types of work site exercise programs have multiple benefits, including reduced neck and shoulder pain for employees who do all-around exercise and lowered heart disease and stroke risk factors for those who do strength training, reports a study in the July Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).

ATS Medical Announces FDA Clearance And First Implant Of New ATS Simulus Semi-Rigid Annuloplasty Band
ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced FDA clearance and the first implant of the ATS Simulus(R) Semi-Rigid Annuloplasty Band. The Simulus Semi-Rigid Annuloplasty Band was developed through the Company"s collaboration with Genesee BioMedical and represents the latest addition to the expanding portfolio of valve repair products.
News of the day
House Approves Bill To End Delay In Veteran Care
The House approved a bill Tuesday that seeks to end waits for federal financing of veterans" health care programs, The New York Times reports.
Endocrinology

UK Court Of Appeal Rules In Smith & Nephew's Favour

Smith & Nephew"s Advanced Wound Management division (NYSE:SNN) announced that the UK Court of Appeal has ruled as invalid all claims asserted against Smith and Nephew of the patent EP 0 626 720 that is licensed to Kinetic Concepts, Inc. (NYSE: KCI). As a result, the preliminary injunction against Smith & Nephew"s RENASYS(TM)-F NPWT system has been lifted. The Patents Court had ruled on 1 May, 2009 that 7 out of 10 claims asserted were invalid but that the remaining 3 had been infringed by Smith & Nephews RENASYS-F dressing. This decision was appealed and subsequently won by Smith & Nephew with today"s Court ruling. "This favourable ruling for Smith & Nephew clears a major legal hurdle in the UK allowing us to offer our customers the breadth of NPWT products with proven clinical efficacy," said Robin Carlstein, Senior Vice President of Advanced Wound Devices at Smith & Nephew. "Clearly, we are pleased with the UK Court of Appeal"s findings in this matter and look forward to servicing our customers with our RENASYS(TM)-F NPWT products in a very important market for the company." Smith & Nephew


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009